{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:24:32Z","timestamp":1786991072048,"version":"build-2736575974"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014554","name":"Hui-Chun Chin and Tsung-Dao Lee Chinese Undergraduate Research Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002782","name":"CURE Childhood Cancer Association","doi-asserted-by":"publisher","award":["22,923"],"award-info":[{"award-number":["22,923"]}],"id":[{"id":"10.13039\/100002782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113711","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T18:01:57Z","timestamp":1733594517000},"page":"113711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Central SGLT2 mediate sympathoexcitation in hypertensive heart failure via attenuating subfornical organ endothelial cGAS ubiquitination to amplify neuroinflammation: Molecular mechanism behind sympatholytic effect of Empagliflozin"],"prefix":"10.1016","volume":"145","author":[{"given":"Shutian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanshun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouguo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail."},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0010","first-page":"722","article-title":"Advanced heart failure epidemiology and outcomes: a population-based study[J]","volume":"9","author":"Dunlay","year":"2021","journal-title":"Heart Failure"},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0015","doi-asserted-by":"crossref","first-page":"e008406","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","article-title":"Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis","volume":"14","author":"Wang","year":"2021","journal-title":"Circ Heart Fail."},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrcardio.2017.139","article-title":"Reverse remodeling and myocardial recovery in heart failure","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Rev Cardiol."},{"issue":"17","key":"10.1016\/j.intimp.2024.113711_b0025","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines[J]","volume":"79","author":"Heidenreich","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jchf.2023.11.005","article-title":"Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping","volume":"12","author":"Dimond","year":"2024","journal-title":"JACC Heart Fail."},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0035","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/ehf2.13169","article-title":"Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis","volume":"7","author":"Butler","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"22","key":"10.1016\/j.intimp.2024.113711_b0040","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.113711_b0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s13340-018-0367-x","article-title":"Pleiotropic effects of SGLT2 inhibitors beyond the effect on glycemic control","volume":"9","author":"Satoh","year":"2018","journal-title":"Diabetol Int."},{"key":"10.1016\/j.intimp.2024.113711_b0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/5584_2020_479","article-title":"Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors","volume":"1307","author":"Kuchay","year":"2021","journal-title":"Adv Exp Med Biol."},{"issue":"10254","key":"10.1016\/j.intimp.2024.113711_b0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet."},{"issue":"15","key":"10.1016\/j.intimp.2024.113711_b0070","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0075","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.1536","article-title":"Evaluation of the effect of sodium-glucose cotransporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial","volume":"21","author":"Packer","year":"2019","journal-title":"Eur J Heart Fail."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10741-023-10345-y","article-title":"The sympathetic nervous system in heart failure revisited","volume":"29","author":"Triposkiadis","year":"2024","journal-title":"Heart Fail Rev."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102411","article-title":"Unraveling the complex pathophysiology of heart failure: insights into the role of renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)","volume":"49","author":"Maryam","year":"2024","journal-title":"Curr Probl Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10286-023-01008-x","article-title":"Central stress pathways in the development of cardiovascular disease","volume":"34","author":"Braun","year":"2024","journal-title":"Clin Auton Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12974-024-03013-x","article-title":"Circulating mitochondria promoted endothelial cGAS-derived neuroinflammation in subfornical organ to aggravate sympathetic overdrive in heart failure mice","volume":"21","author":"Zhang","year":"2024","journal-title":"J Neuroinflammation."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12974-019-1673-3","article-title":"HMGB1\/RAGE axis mediates stress-induced RVLM neuroinflammation in mice by impairing mitophagy flux in microglia","volume":"17","author":"Zhang","year":"2020","journal-title":"J Neuroinflammation."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12264-020-00484-9","article-title":"Microglia-Derived NLRP3 Activation Mediates the Pressor Effect of Prorenin in the Rostral Ventrolateral Medulla of Stress-Induced Hypertensive Rats","volume":"36","author":"Hu","year":"2020","journal-title":"Neurosci Bull."},{"key":"10.1016\/j.intimp.2024.113711_b0115","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.2147\/JIR.S329230","article-title":"PLIN2 Mediates Neuroinflammation and Oxidative\/Nitrosative Stress via Downregulating Phosphatidylethanolamine in the Rostral Ventrolateral Medulla of Stressed Hypertensive Rats","volume":"14","author":"Zhang","year":"2021","journal-title":"J Inflamm Res."},{"issue":"11","key":"10.1016\/j.intimp.2024.113711_b0120","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1007\/s12035-022-02994-1","article-title":"Inhibition of cGAS in Paraventricular Nucleus Attenuates Hypertensive Heart Injury Via Regulating Microglial Autophagy","volume":"59","author":"Han","year":"2022","journal-title":"Mol Neurobiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12974-017-0942-2","article-title":"Neuroinflammation contributes to autophagy flux blockage in the neurons of rostral ventrolateral medulla in stress-induced hypertension rats","volume":"14","author":"Du","year":"2017","journal-title":"J Neuroinflammation."},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MNH.0000000000000767","article-title":"Interaction between sodium-glucose cotransporter 2 and the sympathetic nervous system","volume":"31","author":"Azzam","year":"2022","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101224","article-title":"SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement","volume":"47","author":"Spallone","year":"2021","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.intimp.2024.113711_b0140","doi-asserted-by":"crossref","DOI":"10.1177\/1753944720939383","article-title":"Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activation","volume":"14","author":"Sano","year":"2020","journal-title":"Ther Adv Cardiovasc Dis."},{"key":"10.1016\/j.intimp.2024.113711_b0145","doi-asserted-by":"crossref","unstructured":"Heusser K, Tank J, Diedrich A, Fischer A, Heise T, Jordan J. Randomized Trial Comparing SGLT2 Inhibition and Hydrochlorothiazide on Sympathetic Traffic in Type 2 Diabetes. Kidney Int Rep. 2023;8(11):2254-2264. Published 2023 Sep 3.","DOI":"10.1016\/j.ekir.2023.08.036"},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jacbts.2019.11.007","article-title":"SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection","volume":"5","author":"Herat","year":"2020","journal-title":"JACC Basic Transl Sci."},{"issue":"8","key":"10.1016\/j.intimp.2024.113711_b0155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.tcm.2022.05.005","article-title":"SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure","volume":"33","author":"Gupta","year":"2023","journal-title":"Trends Cardiovasc Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0160","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/s41440-023-01220-2","article-title":"Fluid homeostasis induced by sodium-glucose cotransporter 2 inhibitors: novel insight for better cardio-renal outcomes in chronic kidney disease","volume":"46","author":"Masuda","year":"2023","journal-title":"Hypertens Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11906-022-01170-z","article-title":"Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition","volume":"24","author":"Herat","year":"2022","journal-title":"Curr Hypertens Rep."},{"key":"10.1016\/j.intimp.2024.113711_b0170","doi-asserted-by":"crossref","unstructured":"Zelniker TA, Braunwald E. Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review [published correction appears in J Am Coll Cardiol. 2020 Sep 22;76(12):1505]. J Am Coll Cardiol. 2020;75(4):422-434.","DOI":"10.1016\/j.jacc.2019.11.031"},{"issue":"13","key":"10.1016\/j.intimp.2024.113711_b0175","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.3390\/ijms241310710","article-title":"Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation","volume":"24","author":"Castoldi","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41440-020-0410-8","article-title":"Effects of an SGLT2 inhibitor on the salt sensitivity of blood pressure and sympathetic nerve activity in a nondiabetic rat model of chronic kidney disease","volume":"43","author":"Wan","year":"2020","journal-title":"Hypertens Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113711_b0185","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/bph.15381","article-title":"Inhibition of the sodium-glucose cotransporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation","volume":"178","author":"Yang","year":"2021","journal-title":"Br J Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41440-023-01417-5","article-title":"SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats","volume":"47","author":"Oshima","year":"2024","journal-title":"Hypertens Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0195","doi-asserted-by":"crossref","first-page":"H729","DOI":"10.1152\/ajpheart.00480.2017","article-title":"Circumventing a broken heart: cytokines and the subfornical organ","volume":"313","author":"Yao","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0200","doi-asserted-by":"crossref","first-page":"R741","DOI":"10.1152\/ajpregu.00157.2008","article-title":"Subfornical organ differentially modulates baroreflex function in normotensive and two-kidney, one-clip hypertensive rats","volume":"295","author":"Maliszewska-Scislo","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0205","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.HYP.29.4.1020","article-title":"Effects of subfornical organ lesions on sympathetic nerve responses to insulin","volume":"29","author":"Muntzel","year":"1997","journal-title":"Hypertension."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41392-023-01402-x","article-title":"A kidney-brain neural circuit drives progressive kidney damage and heart failure","volume":"8","author":"Cao","year":"2023","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0215","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/HYPERTENSIONAHA.114.05112","article-title":"Proinflammatory cytokines upregulate sympathoexcitatory mechanisms in the subfornical organ of the rat","volume":"65","author":"Wei","year":"2015","journal-title":"Hypertension."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1113\/expphysiol.2011.060491","article-title":"The role of the subfornical organ in angiotensin II-salt hypertension in the rat","volume":"97","author":"Osborn","year":"2012","journal-title":"Exp Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0225","doi-asserted-by":"crossref","first-page":"H744","DOI":"10.1152\/ajpheart.00280.2017","article-title":"TNF-\u03b1 receptor 1 knockdown in the subfornical organ ameliorates sympathetic excitation and cardiac hemodynamics in heart failure rats","volume":"313","author":"Yu","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.intimp.2024.113711_b0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2018.04.012","article-title":"Angiotensin II Type 1a Receptors in the Subfornical Organ Modulate Neuroinflammation in the Hypothalamic Paraventricular Nucleus in Heart Failure Rats","volume":"381","author":"Yu","year":"2018","journal-title":"Neuroscience."},{"issue":"8","key":"10.1016\/j.intimp.2024.113711_b0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1152\/physiolgenomics.00021.2019","article-title":"Subfornical organ insulin receptors tonically modulate cardiovascular and metabolic function","volume":"51","author":"Jeong","year":"2019","journal-title":"Physiol Genomics."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.113.01404","article-title":"Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines","volume":"62","author":"Wei","year":"2013","journal-title":"Hypertension."},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0245","doi-asserted-by":"crossref","first-page":"e13704","DOI":"10.14814\/phy2.13704","article-title":"Brain-derived neurotrophic factor acts at neurons of the subfornical organ to influence cardiovascular function","volume":"6","author":"Black","year":"2018","journal-title":"Physiol Rep."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0250","doi-asserted-by":"crossref","first-page":"H796","DOI":"10.1152\/ajpheart.00616.2017","article-title":"Increased (pro)renin receptor expression in the subfornical organ of hypertensive humans","volume":"314","author":"Cooper","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0255","doi-asserted-by":"crossref","first-page":"R425","DOI":"10.1152\/ajpregu.00044.2018","article-title":"Tumor necrosis factor-\u03b1 potentiates the effects of angiotensin II on subfornical organ neurons","volume":"315","author":"Simpson","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0260","doi-asserted-by":"crossref","first-page":"e0231844","DOI":"10.1371\/journal.pone.0231844","article-title":"Increased apelin receptor gene expression in the subfornical organ of spontaneously hypertensive rats","volume":"15","author":"Griffiths","year":"2020","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.119.12651","article-title":"Brain TACE (Tumor Necrosis Factor-\u03b1-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats","volume":"74","author":"Yu","year":"2019","journal-title":"Hypertension."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113711_b0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01697-2","article-title":"Pharmacological characterization of amylin-related peptides activating subfornical organ neurones","volume":"837","author":"Riediger","year":"1999","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0275","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/alcalc\/agh079","article-title":"Role of angiotensin II and the subfornical organ in the pharmacological actions of ethanol","volume":"39","author":"Grobe","year":"2004","journal-title":"Alcohol Alcohol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0280","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/WNR.0b013e32835ffc14","article-title":"Insulin modulates the electrical activity of subfornical organ neurons","volume":"24","author":"Lakhi","year":"2013","journal-title":"Neuroreport."},{"issue":"9","key":"10.1016\/j.intimp.2024.113711_b0285","doi-asserted-by":"crossref","first-page":"e12613","DOI":"10.1111\/jne.12613","article-title":"The subfornical organ: A novel site for prolactin action","volume":"30","author":"Kamesh","year":"2018","journal-title":"J Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0290","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ando.2023.03.010","article-title":"Drug-induced syndrome of inappropriate diuresis or of antidiuretic hormone secretion?","volume":"84","author":"Haymann","year":"2023","journal-title":"Ann Endocrinol (paris)."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0295","doi-asserted-by":"crossref","first-page":"R363","DOI":"10.1152\/ajpregu.00462.2013","article-title":"The subfornical organ: a novel site of action of cholecystokinin","volume":"306","author":"Ahmed","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"10.1016\/j.intimp.2024.113711_b0300","doi-asserted-by":"crossref","unstructured":"Preda A, Montecucco F, Carbone F, et al. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovasc Res. Published online March 8, 2024.","DOI":"10.1093\/cvr\/cvae047"},{"issue":"9","key":"10.1016\/j.intimp.2024.113711_b0305","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.7150\/thno.54498","article-title":"Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to preclinical and clinical therapeutics","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics."},{"issue":"11","key":"10.1016\/j.intimp.2024.113711_b0310","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.7150\/thno.75121","article-title":"SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia\/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0315","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00210-023-02607-1","article-title":"Empagliflozin reduces endoplasmic reticulum stress associated TXNIP\/NLRP3 activation in tunicamycin-stimulated aortic endothelial cells","volume":"397","author":"Campeau","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"17","key":"10.1016\/j.intimp.2024.113711_b0320","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.3390\/ijerph20176671","article-title":"Immunomodulatory Effects of SGLT2 Inhibitors-Targeting Inflammation and Oxidative Stress in Aging","volume":"20","author":"Sch\u00f6nberger","year":"2023","journal-title":"Int J Environ Res Public Health."},{"key":"10.1016\/j.intimp.2024.113711_b0325","article-title":"SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant","author":"Guo","year":"2023156809952","journal-title":"Sci Transl Med."},{"issue":"8","key":"10.1016\/j.intimp.2024.113711_b0330","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/HYPERTENSIONAHA.122.19586","article-title":"SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients","volume":"79","author":"Mone","year":"2022","journal-title":"Hypertension."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0335","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1038\/s41598-023-33086-2","article-title":"SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction","volume":"13","author":"Dhakal","year":"2023","journal-title":"Sci Rep."},{"key":"10.1016\/j.intimp.2024.113711_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115213","article-title":"Dapagliflozin prevents oxidative stress-induced endothelial dysfunction via sirtuin 1 activation","volume":"165","author":"Zhou","year":"2023","journal-title":"Biomed Pharmacother."},{"issue":"16","key":"10.1016\/j.intimp.2024.113711_b0345","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signaling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.intimp.2024.113711_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106062","article-title":"Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment","volume":"176","author":"Rizzo","year":"2022","journal-title":"Pharmacol Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0355","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acschemneuro.0c00722","article-title":"Targeting ROS-Dependent AKT\/GSK-3\u03b2\/NF-\u03baB and DJ-1\/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model","volume":"12","author":"Arab","year":"2021","journal-title":"ACS Chem Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/biomedicines12010036","article-title":"SGLT2 Inhibitor Canagliflozin Alleviates High Glucose-Induced Inflammatory Toxicity in BV-2 Microglia","volume":"12","author":"Lee","year":"2023","journal-title":"Biomedicines."},{"issue":"19","key":"10.1016\/j.intimp.2024.113711_b0365","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/cells11193107","article-title":"Anti-Inflammatory Properties of the SGLT2 Inhibitor Empagliflozin in Activated Primary Microglia","volume":"11","author":"Heimke","year":"2022","journal-title":"Cells."},{"issue":"12","key":"10.1016\/j.intimp.2024.113711_b0370","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/antiox10121935","article-title":"Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors","volume":"10","author":"Lin","year":"2021","journal-title":"Antioxidants (basel)."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0375","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10787-023-01384-w","article-title":"Empagliflozin repurposing in Parkinson's disease; modulation of oxidative stress, neuroinflammation, AMPK\/SIRT-1\/PGC-1\u03b1, and wnt\/\u03b2-catenin pathways","volume":"32","author":"Mohammed","year":"2024","journal-title":"Inflammopharmacology."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0380","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12933-024-02174-6","article-title":"The SGLT2 inhibitor Empagliflozin promotes poststroke functional recovery in diabetic mice","volume":"23","author":"Vercalsteren","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.intimp.2024.113711_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115840","article-title":"Central administration of Dapagliflozin alleviates a hypothalamic neuroinflammatory signature and changing tubular lipid metabolism in type 2 diabetic nephropathy by upregulating MCPIP1","volume":"168","author":"Da","year":"2023","journal-title":"Biomed Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0390","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1007\/s13311-021-01140-4","article-title":"Crosstalk Among NLRP3 Inflammasome, ETBR Signaling, and miRNAs in Stress-Induced Depression-Like Behavior: a Modulatory Role for SGLT2 Inhibitors","volume":"18","author":"Muhammad","year":"2021","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.intimp.2024.113711_b0395","doi-asserted-by":"crossref","unstructured":"Wang C, Zhang R, He J, et al. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity. Nat Commun. 2023;14(1):3877. Published 2023 Jun 30. doi:10.1038\/s41467-023-39607-x.","DOI":"10.1038\/s41467-023-39607-x"},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0400","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell."},{"issue":"14","key":"10.1016\/j.intimp.2024.113711_b0405","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-\u03baB that mediate immune defense against tumors and viral infections","volume":"118","author":"Yum","year":"2021","journal-title":"Proc Natl Acad Sci U S a."},{"issue":"14","key":"10.1016\/j.intimp.2024.113711_b0410","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.cell.2023.05.039","article-title":"Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity","volume":"186","author":"Lei","year":"2023","journal-title":"Cell."},{"issue":"11","key":"10.1016\/j.intimp.2024.113711_b0415","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1161\/CIRCRESAHA.122.321587","article-title":"Critical Role of the cGAS-STING Pathway in Doxorubicin-Induced Cardiotoxicity","volume":"132","author":"Luo","year":"2023","journal-title":"Circ Res."},{"issue":"21","key":"10.1016\/j.intimp.2024.113711_b0420","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.7150\/thno.47651","article-title":"HDAC3 inhibition ameliorates ischemia\/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway","volume":"10","author":"Liao","year":"2020","journal-title":"Theranostics."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0425","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41593-023-01315-6","article-title":"Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience","volume":"26","author":"Udeochu","year":"2023","journal-title":"Nat Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0430","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41392-020-0171-5","article-title":"ALDH2 contributes to melatonin-induced protection against APP\/PS1 mutation-prompted cardiac anomalies through cGAS-STING-TBK1-mediated regulation of mitophagy","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther."},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0435","doi-asserted-by":"crossref","first-page":"H1525","DOI":"10.1152\/ajpheart.00097.2020","article-title":"Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure","volume":"318","author":"Hu","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0440","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41420-022-01046-w","article-title":"Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov."},{"issue":"12","key":"10.1016\/j.intimp.2024.113711_b0445","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type I interferons fuel a fatal response to myocardial infarction","volume":"23","author":"King","year":"2017","journal-title":"Nat Med."},{"issue":"7","key":"10.1016\/j.intimp.2024.113711_b0450","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.7150\/thno.83340","article-title":"OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0455","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","article-title":"USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes","volume":"132","author":"Ye","year":"2023","journal-title":"Circ Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.113711_b0460","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","article-title":"Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3","volume":"126","author":"Ye","year":"2020","journal-title":"Circ Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0465","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI88641","article-title":"Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism","volume":"127","author":"Claflin","year":"2017","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0470","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/s41467-020-19191-0","article-title":"Distinct CCK-positive SFO neurons are involved in persistent or transient suppression of water intake","volume":"11","author":"Matsuda","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0475","doi-asserted-by":"crossref","first-page":"e002104","DOI":"10.1136\/bmjdrc-2020-002104","article-title":"Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats","volume":"9","author":"Takeda","year":"2021","journal-title":"BMJ Open Diabetes Res Care."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0480","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/molecules28031112","article-title":"SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol","volume":"28","author":"Pawlos","year":"2023","journal-title":"Molecules."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0485","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1080\/13880209.2022.2142801","article-title":"Catalpol relieved angiotensin II-induced bloodbrain barrier destruction by inhibiting the TLR4 pathway in brain endothelial cells","volume":"60","author":"Xia","year":"2022","journal-title":"Pharm Biol."},{"key":"10.1016\/j.intimp.2024.113711_b0490","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2814","article-title":"Astrocytic lipid metabolism determines susceptibility to diet-induced obesity","author":"Varela","year":"20217502814","journal-title":"Sci Adv."},{"key":"10.1016\/j.intimp.2024.113711_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103085","article-title":"Neurogranin expression regulates mitochondrial function and redox balance in endothelial cells","volume":"70","author":"Jorgensen","year":"2024","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0500","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00395-019-0722-5","article-title":"Inflammation and fibrosis in murine models of heart failure","volume":"114","author":"Bacmeister","year":"2019","journal-title":"Basic Res Cardiol."},{"issue":"27","key":"10.1016\/j.intimp.2024.113711_b0505","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodeling postmyocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0510","doi-asserted-by":"crossref","first-page":"e148554","DOI":"10.1172\/JCI148554","article-title":"Therapeutic targets for cardiac fibrosis: from old school to next-gen","volume":"132","author":"Travers","year":"2022","journal-title":"J Clin Invest."},{"issue":"21","key":"10.1016\/j.intimp.2024.113711_b0515","doi-asserted-by":"crossref","first-page":"13311","DOI":"10.3390\/ijms232113311","article-title":"Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart Failure","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"9","key":"10.1016\/j.intimp.2024.113711_b0520","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1139\/cjpp-2019-0044","article-title":"Role of catecholamines in the pathogenesis of diabetic cardiomyopathy","volume":"97","author":"Dhalla","year":"2019","journal-title":"Can J Physiol Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0525","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00395-022-00939-2","article-title":"Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model","volume":"117","author":"Zhou","year":"2022","journal-title":"Basic Res Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0530","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00395-023-01026-w","article-title":"Targeted ablation of the left middle cervical ganglion prevents ventricular arrhythmias and cardiac injury induced by AMI","volume":"119","author":"Zheng","year":"2024","journal-title":"Basic Res Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0535","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/jcmm.14000","article-title":"Bilateral sympathetic stellate ganglionectomy attenuates myocardial remodeling and fibrosis in a rat model of chronic volume overload","volume":"23","author":"Zhang","year":"2019","journal-title":"J Cell Mol Med."},{"issue":"24","key":"10.1016\/j.intimp.2024.113711_b0540","doi-asserted-by":"crossref","first-page":"13678","DOI":"10.3390\/ijms222413678","article-title":"Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension","volume":"22","author":"Castoldi","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"7","key":"10.1016\/j.intimp.2024.113711_b0545","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/cvr\/cvab209","article-title":"Noninvasive transcutaneous vagal nerve stimulation improves myocardial performance in doxorubicin-induced cardiotoxicity","volume":"118","author":"Lai","year":"2022","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.intimp.2024.113711_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102937","article-title":"Cardiomyocyte NOX4 regulates resident macrophage-mediated inflammation and diastolic dysfunction in stress cardiomyopathy","volume":"67","author":"Vendrov","year":"2023","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0555","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650.2020.1752918","article-title":"Treatment for beta-blocker poisoning: a systematic review","volume":"58","author":"Rotella","year":"2020","journal-title":"Clin Toxicol (phila)."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0560","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bcp.12763","article-title":"Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies","volume":"81","author":"Graudins","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.intimp.2024.113711_b0565","doi-asserted-by":"crossref","first-page":"1064955","DOI":"10.1155\/2023\/1064955","article-title":"A Clinical-Epidemiological Study on Beta-Blocker Poisonings Based on the Type of Drug Overdose","volume":"2023","author":"Eizadi-Mood","year":"2023","journal-title":"J Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0570","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.37765\/ajmc.2022.88844","article-title":"Adverse drug effects across patients with heart failure: a systematic review","volume":"28","author":"Butzner","year":"2022","journal-title":"Am J Manag Care."},{"key":"10.1016\/j.intimp.2024.113711_b0575","article-title":"Brain-heart interaction after acute ischemic stroke","volume":"24(1):163","author":"Battaglini","year":"2020","journal-title":"Crit Care."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0580","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1113\/JP278864","article-title":"Neuroinflammation in heart failure: new insights for an old disease","volume":"598","author":"D\u00edaz","year":"2020","journal-title":"J Physiol."},{"key":"10.1016\/j.intimp.2024.113711_b0585","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.phrs.2019.04.029","article-title":"Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways","volume":"144","author":"Mowry","year":"2019","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.intimp.2024.113711_b0590","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autneu.2018.01.002","article-title":"Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension","volume":"210","author":"Haspula","year":"2018","journal-title":"Auton Neurosci."},{"key":"10.1016\/j.intimp.2024.113711_b0595","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2147\/JIR.S350109","article-title":"Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases","volume":"15","author":"Wang","year":"2022","journal-title":"J Inflamm Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0600","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/HYPERTENSIONAHA.122.20782","article-title":"Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension","volume":"80","author":"Razee","year":"2023","journal-title":"Hypertension."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0605","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00395-021-00871-x","article-title":"Macrophage depletion in stellate ganglia alleviates cardiac sympathetic overactivation and ventricular arrhythmogenesis by attenuating neuroinflammation in heart failure","volume":"116","author":"Zhang","year":"2021","journal-title":"Basic Res Cardiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0610","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/HYPERTENSIONAHA.121.18219","article-title":"IL (Interleukin)-17A Acts in the Brain to Drive Neuroinflammation, Sympathetic Activation, and Hypertension","volume":"78","author":"Cao","year":"2021","journal-title":"Hypertension."},{"key":"10.1016\/j.intimp.2024.113711_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104677","article-title":"Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide","volume":"153","author":"Donertas Ayaz","year":"2020","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.intimp.2024.113711_b0620","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu Rev Physiol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0625","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.intimp.2024.113711_b0630","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/ejhf.2915","article-title":"Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial","volume":"25","author":"Chatur","year":"2023","journal-title":"Eur J Heart Fail."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0635","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-020-01127-z","article-title":"Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial","volume":"19","author":"Shimizu","year":"2020","journal-title":"Cardiovasc Diabetol."},{"issue":"15","key":"10.1016\/j.intimp.2024.113711_b0640","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.intimp.2024.113711_b0645","doi-asserted-by":"crossref","first-page":"1012220","DOI":"10.3389\/fcvm.2022.1012220","article-title":"In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study","volume":"9","author":"Cesaro","year":"2022","journal-title":"Front Cardiovasc Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0650","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41440-023-01522-5","article-title":"Inhibiting SGLTs diminishes sympathetic output by reducing rostral ventrolateral medulla (RVLM) neuron activity","volume":"47","author":"Rahman","year":"2024","journal-title":"Hypertens Res."},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0655","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41401-022-00885-8","article-title":"Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1\/MAPK signaling","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol Sin."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0660","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s42003-023-04663-y","article-title":"The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice","volume":"6","author":"Choi","year":"2023","journal-title":"Commun Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0665","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering of cytosolic Na+ and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia."},{"issue":"7","key":"10.1016\/j.intimp.2024.113711_b0670","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacbts.2019.10.005","article-title":"Empagliflozin and HFrEF: Known and Possible Benefits of NHE1 Inhibition","volume":"4","author":"Jun","year":"2019","journal-title":"JACC Basic Transl Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0675","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1002\/ehf2.13024","article-title":"Empagliflozin inhibits Na+\/H+ exchanger activity in human atrial cardiomyocytes","volume":"7","author":"Trum","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"10","key":"10.1016\/j.intimp.2024.113711_b0680","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/cvr\/cvz004","article-title":"Delayed ischemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts","volume":"115","author":"Uthman","year":"2019","journal-title":"Cardiovasc Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0685","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.intimp.2024.113711_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102288","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion through activating the AMPK\u03b11\/ULK1\/FUNDC1\/mitophagy pathway","volume":"52","author":"Cai","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0695","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in nondiabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.intimp.2024.113711_b0700","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","article-title":"Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission","volume":"15","author":"Zhou","year":"2018","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0705","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","article-title":"Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation","volume":"117","author":"Kolijn","year":"2021","journal-title":"Cardiovasc Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0710","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12933-023-02040-x","article-title":"SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1","volume":"22","author":"Wang","year":"2023","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.intimp.2024.113711_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114448","article-title":"Dapagliflozin inhibits the activity of lateral habenula to alleviate diabetes mellitus-induced depressive-like behavior","volume":"366","author":"Dong","year":"2023","journal-title":"Exp Neurol."},{"issue":"18","key":"10.1016\/j.intimp.2024.113711_b0720","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3390\/cells12182221","article-title":"Canagliflozin, an Inhibitor of the Na+-Coupled D-Glucose Cotransporter, SGLT2, Inhibits Astrocyte Swelling and Brain Swelling in Cerebral Ischemia","volume":"12","author":"Shim","year":"2023","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0725","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s42003-022-03605-4","article-title":"Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects","volume":"5","author":"Takashima","year":"2022","journal-title":"Commun Biol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0730","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","article-title":"Neuroinflammation, Stroke, BloodBrain Barrier Dysfunction, and Imaging Modalities","volume":"53","author":"Candelario-Jalil","year":"2022","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0735","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0740","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms23010014","article-title":"Neuroinflammation in Cerebral Ischemia and Ischemia\/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies","volume":"23","author":"Jurcau","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0745","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J Neuroinflammation."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0750","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.intimp.2024.113711_b0755","doi-asserted-by":"crossref","unstructured":"Khedr LH, Rahmo RM, Eldemerdash OM, et al. Implication of M2 macrophage on NLRP3 inflammasome signaling in mediating the neuroprotective effect of Canagliflozin against methotrexate-induced cognitive impairment. Int Immunopharmacol. Published online February 19, 2024.","DOI":"10.1016\/j.intimp.2024.111709"},{"key":"10.1016\/j.intimp.2024.113711_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109368","article-title":"Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK\/mTOR, HMGB1\/RAGE and Nrf2\/HO-1 pathways","volume":"335","author":"Arab","year":"2021","journal-title":"Chem Biol Interact."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0765","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.celrep.2019.09.050","article-title":"Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury","volume":"29","author":"Maekawa","year":"2019","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0770","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","article-title":"Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0775","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","article-title":"The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy","volume":"12","author":"Oduro","year":"2022","journal-title":"Acta Pharm Sin b."},{"issue":"4","key":"10.1016\/j.intimp.2024.113711_b0780","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/15548627.2020.1739447","article-title":"Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0785","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","article-title":"The interaction between ferroptosis and inflammatory signaling pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.113711_b0790","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cas.14266","article-title":"Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer","volume":"111","author":"Loo","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2024.113711_b0795","doi-asserted-by":"crossref","unstructured":"Victorelli S, Salmonowicz H, Chapman J, et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP [published correction appears in Nature. 2024 Jan;625(7995):E15]. Nature. 2023;622(7983):627-636.","DOI":"10.1038\/s41586-023-06621-4"},{"issue":"9","key":"10.1016\/j.intimp.2024.113711_b0800","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Gl\u00fcck","year":"2017","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.intimp.2024.113711_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110022","article-title":"STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress","volume":"125","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0810","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/FJC.0000000000001465","article-title":"The STING-IRF3 Signaling Pathway, Mediated by Endoplasmic Reticulum Stress, Contributes to Impaired Myocardial Autophagic Flux After Ischemia\/Reperfusion","volume":"82","author":"Li","year":"2023","journal-title":"J Cardiovasc Pharmacol."},{"issue":"15","key":"10.1016\/j.intimp.2024.113711_b0815","doi-asserted-by":"crossref","first-page":"e020754","DOI":"10.1161\/JAHA.121.020754","article-title":"Plasmacytoid Dendritic Cells Mediate Myocardial Ischemia\/Reperfusion Injury by Secreting Type I Interferons","volume":"10","author":"Lai","year":"2021","journal-title":"J Am Heart Assoc."},{"issue":"24","key":"10.1016\/j.intimp.2024.113711_b0820","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/CIRCULATIONAHA.117.031046","article-title":"Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury","volume":"137","author":"Cao","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.intimp.2024.113711_b0825","doi-asserted-by":"crossref","unstructured":"Mao Y, Luo W, Zhang L, et al. STING-IRF3 Triggers Endothelial Inflammation in Response to Free Fatty Acid-Induced Mitochondrial Damage in Diet-Induced Obesity [published correction appears in Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):e60]. Arterioscler Thromb Vasc Biol. 2017;37(5):920-929.","DOI":"10.1161\/ATVBAHA.117.309017"},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0830","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/ajt.17034","article-title":"IFI16-STING-NF-\u03baB signaling controls exogenous mitochondrion-induced endothelial activation","volume":"22","author":"Li","year":"2022","journal-title":"Am J Transplant."},{"issue":"21","key":"10.1016\/j.intimp.2024.113711_b0835","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3390\/cells12212555","article-title":"Myocardial Mitochondrial DNA Drives Macrophage Inflammatory Response through STING Signaling in Coxsackievirus B3-Induced Viral Myocarditis","volume":"12","author":"Qin","year":"2023","journal-title":"Cells."},{"issue":"7956","key":"10.1016\/j.intimp.2024.113711_b0840","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41586-023-05862-7","article-title":"Ubiquitin-like conjugation by bacterial cGAS enhances anti-phage defense","volume":"616","author":"Jenson","year":"2023","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0845","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1038\/s41467-022-33671-5","article-title":"The E3 ubiquitin ligase ARIH1 promotes antiviral immunity and autoimmunity by inducing mono-ISGylation and oligomerization of cGAS","volume":"13","author":"Xiong","year":"2022","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0850","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12985-022-01785-3","article-title":"HBx inhibits DNA sensing signaling pathway via ubiquitination and autophagy of cGAS","volume":"19","author":"Chen","year":"2022","journal-title":"Virol J."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0855","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/15548627.2022.2139921","article-title":"Tegument protein UL21 of alpha-herpesvirus inhibits the innate immunity by triggering CGAS degradation through TOLLIP-mediated selective autophagy","volume":"19","author":"Ma","year":"2023","journal-title":"Autophagy."},{"issue":"1","key":"10.1016\/j.intimp.2024.113711_b0860","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-023-02804-y","article-title":"The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage","volume":"20","author":"Zhu","year":"2023","journal-title":"J Neuroinflammation."},{"issue":"6","key":"10.1016\/j.intimp.2024.113711_b0865","doi-asserted-by":"crossref","first-page":"e13622","DOI":"10.1111\/acel.13622","article-title":"Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation","volume":"21","author":"Zhong","year":"2022","journal-title":"Aging Cell."},{"key":"10.1016\/j.intimp.2024.113711_b0870","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abk3067","article-title":"MARCH8 attenuates cGAS-mediated innate immune responses through ubiquitylation","author":"Yang","year":"2022157323067","journal-title":"Sci Signal."},{"issue":"16","key":"10.1016\/j.intimp.2024.113711_b0875","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1111\/bph.15850","article-title":"Amelioration of endothelial dysfunction by sodium glucose cotransporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection","volume":"179","author":"Li","year":"2022","journal-title":"Br J Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113711_b0880","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/jcmm.14233","article-title":"Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence","volume":"24","author":"Khemais-Benkhiat","year":"2020","journal-title":"J Cell Mol Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113711_b0885","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.14336\/AD.2020.1229","article-title":"The Role of SGLT2 Inhibitors in Vascular Aging","volume":"12","author":"Liu","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.intimp.2024.113711_b0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106949","article-title":"Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: A potential rescue strategy","volume":"142","author":"Madonna","year":"2022","journal-title":"Vascul Pharmacol."},{"key":"10.1016\/j.intimp.2024.113711_b0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/MSMBR.907775","article-title":"Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K\/AKT\/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO)","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit Basic Res."},{"key":"10.1016\/j.intimp.2024.113711_b0900","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2022.03.005","article-title":"Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects","volume":"167","author":"Dyck","year":"2022","journal-title":"J Mol Cell Cardiol."},{"key":"10.1016\/j.intimp.2024.113711_b0905","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.810791","article-title":"Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey","volume":"8","author":"Cappetta","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.intimp.2024.113711_b0910","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med."},{"issue":"18","key":"10.1016\/j.intimp.2024.113711_b0915","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling\/Autophagy Hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation."},{"key":"10.1016\/j.intimp.2024.113711_b0920","doi-asserted-by":"crossref","first-page":"1138499","DOI":"10.3389\/fphar.2023.1138499","article-title":"Hypoglycemic medicines in the treatment of Alzheimer's disease: Pathophysiological links between AD and glucose metabolism","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol."},{"issue":"21","key":"10.1016\/j.intimp.2024.113711_b0925","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.3390\/molecules27217174","article-title":"Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder","volume":"27","author":"Nakhal","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.intimp.2024.113711_b0930","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2147\/DMSO.S375559","article-title":"The Relationship Between the BloodBrain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors","volume":"15","author":"Dong","year":"2022","journal-title":"Diabetes Metab Syndr Obes."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T19:41:25Z","timestamp":1734637285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924022331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":186,"alternative-id":["S1567576924022331"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113711","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central SGLT2 mediate sympathoexcitation in hypertensive heart failure via attenuating subfornical organ endothelial cGAS ubiquitination to amplify neuroinflammation: Molecular mechanism behind sympatholytic effect of Empagliflozin","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113711"}}